Australia markets close in 2 hours 29 minutes

Hofseth BioCare ASA (HOFBF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.2021-0.0013 (-0.64%)
At close: 12:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 79.30M
Enterprise value 92.60M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.22
Price/book (mrq)5.41
Enterprise value/revenue 4.83
Enterprise value/EBITDA -1.27

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-79.79%
S&P500 52-week change 323.33%
52-week high 31.0000
52-week low 30.1700
50-day moving average 30.1985
200-day moving average 30.4720

Share statistics

Avg vol (3-month) 31.33k
Avg vol (10-day) 31.99k
Shares outstanding 5395.08M
Implied shares outstanding 6455.48M
Float 8188.59M
% held by insiders 158.22%
% held by institutions 141.32%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in NOK.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -43.28%
Operating margin (ttm)-50.06%

Management effectiveness

Return on assets (ttm)-14.75%
Return on equity (ttm)-72.94%

Income statement

Revenue (ttm)226.1M
Revenue per share (ttm)0.56
Quarterly revenue growth (yoy)17.00%
Gross profit (ttm)N/A
EBITDA -77.55M
Net income avi to common (ttm)-97.85M
Diluted EPS (ttm)-0.0200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)22.16M
Total cash per share (mrq)0.05
Total debt (mrq)162.59M
Total debt/equity (mrq)104.45%
Current ratio (mrq)0.99
Book value per share (mrq)0.38

Cash flow statement

Operating cash flow (ttm)-16.78M
Levered free cash flow (ttm)-121.33M